Jaka jest cena za Odyssey Therapeutics, Inc. (ODTX)

Cena za Odyssey Therapeutics, Inc. (ODTX) wynosi $24.55

Jaka jest kapitalizacja rynkowa dla Odyssey Therapeutics, Inc. (ODTX)

Kapitalizacja rynkowa dla Odyssey Therapeutics, Inc. (ODTX) wynosi $1.18B

Odyssey Therapeutics, Inc. (ODTX) Historia Cen

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.

Rok	Wydajność
Za mało danych dla podanych dat.

Rok

Wydajność

Za mało danych dla podanych dat.

Firma	Cena akcji	Zmiana 1r%	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Firma

Cena akcji

Zmiana 1r%

Kraj